M2-polarized tumor-associated macrophages promoted epithelial–mesenchymal transition in pancreatic cancer cells, partially through TLR4/IL-10 signaling pathway

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Laboratory Investigation

• Publication date

  2013-06-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/labinvest.2013.69PMID 23752129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pancreatic cancer.

  2013cited by this paper
• BMP-6 in renal cell carcinoma promotes tumor proliferation through IL-10-dependent M2 polarization of tumor-associated macrophages.

  2013cited by this paper
• CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.

  2012cited by this paper
• Immunology in the clinic review series; focus on cancer: tumour‐associated macrophages: undisputed stars of the inflammatory tumour microenvironment

  2012cited by this paper
• Differentiation and gene expression profile of tumor-associated macrophages.

  2012cited by this paper
• CD146 Expression Correlates with Epithelial-Mesenchymal Transition Markers and a Poor Prognosis in Gastric Cancer

  2012cited by this paper
• Cancer stem cells and EMT in carcinoma

  2012cited by this paper
• Characteristics of Suppressor Macrophages Induced by Mycobacterial and Protozoal Infections in relation to Alternatively Activated M2 Macrophages

  2012cited by this paper
• Interferon-gamma and interleukin-10 production by mononuclear cells from patients with advanced head and neck cancer

  2012cited by this paper
• Gadd45a sensitizes medulloblastoma cells to irradiation and suppresses MMP-9-mediated EMT.

  2011cited by this paper
• TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophages.

  2011cited by this paper
• Significance of M2-polarized tumor-associated macrophage in pancreatic cancer.

  2011cited by this paper
• Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

  2011cited by this paper
• IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway

  2011cited by this paper
• Pancreatic cancer.

  2010cited by this paper
• Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T‐cell lymphoma (AITL)

  2010cited by this paper
• Primers on Molecular Pathways: Lipopolysaccharide Signaling – Potential Role in Pancreatitis and Pancreatic Cancer

  2010cited by this paper
• Toll-like Receptor 4 Signaling Promotes Tumor Growth

  2010cited by this paper
• Proteomic analysis of tumor necrosis factor-α resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype

  2008cited by this paper
• Toll-like receptors in inflammation, infection and cancer.

  2007cited by this paper
• Masquerader: High Mobility Group Box-1 and Cancer

  2007cited by this paper
• Epithelial-Mesenchymal Transition (EMT) and Activated Extracellular Signal-regulated Kinase (p-Erk) in Surgically Resected Pancreatic Cancer

  2007cited by this paper
• Loss of WISP-2/CCN5 signaling in human pancreatic cancer: a potential mechanism for epithelial-mesenchymal-transition.

  2007cited by this paper
• A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation).

  2006cited by this paper
• Intravital imaging of cell movement in tumours

  2003cited by this paper
• Holliday Junction Resolution Is Modulated by Archaeal Chromatin Components in Vitro *

  2002cited by this paper
• Phosphatidylinositol 3-Kinase Activity Negatively Regulates Stability of Cyclooxygenase 2 mRNA*

  2002cited by this paper

• Advanced Drug Delivery Strategies for Overcoming Biological Barriers: Tumor Microenvironment and Blood-Brain Barrier.

  2026cites this paper
• Cytokine circuitry in pancreatic cancer: Targets for overcoming immune checkpoint inhibitor resistance in PDAC.

  2026cites this paper
• Mechanistic insights into inflammatory cytokines in adenomyosis‑induced infertility (Review).

  2026cites this paper
• Based on the immune system: the role of the IL-2 family in pancreatic disease

  2025cites this paper
• Targeting tumor-associated macrophages in colon cancer: mechanisms and therapeutic strategies

  2025cites this paper
• Immunosuppressive tumor microenvironment in pancreatic cancer: mechanisms and therapeutic targets

  2025cites this paper
• The Anti-EMMPRIN Monoclonal Antibody hMR18-mAb Induces Tumor Dormancy and Inhibits the EMT Process in Human Carcinoma Cell Lines Co-Cultured with Macrophages

  2025cites this paper
• The role of inflammatory factors in the tumor microenvironment of pancreatic cancer

  2025cites this paper
• Oral Treatment with the Vimentin-Targeting Compound ALD-R491 Mitigates Hyperinflammation, Multi-Organ Injury, and Mortality in CLP-Induced Septic Mice

  2025cites this paper
• The effects of n-3 PUFAs on colorectal cancer carcinogenesis: comprehensive review

  2025cites this paper
• Exosomal miR-552-5p Regulates the Role of NK Cells in EMT of Gastric Cancer via the PD-1/PD-L1 Axis

  2025cites this paper
• Glucose Metabolism Reprogramming of Immune Cells in the Microenvironment of Pancreatic and Hepatobiliary Cancers

  2025cites this paper
• The role of macrophages in liver metastasis: mechanisms and therapeutic prospects

  2025cites this paper
• Circulating Cell-Free Mitochondrial DNA and Inflammation in Older Adults with Pancreatic Cancer: Results from an Exploratory Study

  2025cites this paper
• Regulatory T Cells in Colon Cancer: Implications for Pathogenesis, Prognosis and Emerging Therapeutic Strategies

  2025cites this paper
• Harnessing Macrophages in Cancer Therapy: from Immune Modulators to Therapeutic Targets

  2025cites this paper
• The kinase ERK plays a conserved dominant role in the heterogeneity of epithelial-mesenchymal transition in pancreatic cancer cells.

  2025cites this paper
• The Tumor Environment in Peritoneal Carcinomatosis and Malignant Pleural Effusions: Implications for Therapy

  2025cites this paper
• Oligonucleotide‐Based Modulation of Macrophage Polarization: Emerging Strategies in Immunotherapy

  2025cites this paper
• Cedrol impedes lung cancer metastasis by reducing tumor-associated macrophage polarization mediated by MYC-driven aerobic glycolysis

  2025cites this paper
• The role and clinical significance of tumor-associated macrophages in the epithelial–mesenchymal transition of lung cancer

  2025cites this paper
• Research progress on the anti-cancer mechanisms of edible salty-flavored Chinese materia medica

  2025cites this paper
• Paricalcitol plus hydroxychloroquine enhances gemcitabine activity and induces mesenchymal to epithelial transition in pancreatic ductal adenocarcinoma: A single cell RNA-seq analysis.

  2025cites this paper
• Cathepsin C correlates with M2 macrophage infiltration and regulates the tumor growth and metastasis in non-small cell lung cancer

  2025cites this paper
• UBE2I promotes immune infiltration and tumor progression in thyroid cancer and modulates hnRNPA2B1 SUMOylation

  2025cites this paper
• The role of intestinal macrophage polarization in colitis-associated colon cancer

  2025cites this paper
• Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease

  2025cites this paper
• Tumor‐Associated Macrophages: Key Players in the Non‐Small Cell Lung Cancer Tumor Microenvironment

  2025cites this paper
• Inflammation, microbiota, and pancreatic cancer

  2025cites this paper
• A new perspective on the therapeutic potential of tumor metastasis: targeting the metabolic interactions between TAMs and tumor cells

  2024cites this paper
• MicroRNA-382 as a tumor suppressor during tumor progression.

  2024cites this paper
• Interleukin 4 and cancer resistance in glioblastoma multiforme

  2024cites this paper
• VISTA in hematological malignancies: a review of the literature

  2024cites this paper
• Identification of common core genes and pathways in childhood sepsis and cancer by bioinformatics analysis

  2024cites this paper
• The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets

  2024cites this paper
• Electrospun fiber‐based immune engineering in regenerative medicine

  2024cites this paper
• 3D histology reveals that immune response to pancreatic precancers is heterogeneous and depends on global pancreas structure

  2024cites this paper
• Legumain‐Guided Ferulate‐Peptide Self‐Assembly Enhances Macrophage‐Endotheliocyte Partnership to Promote Therapeutic Angiogenesis After Myocardial Infarction

  2024cites this paper
• Polarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy.

  2024cites this paper
• Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets

  2024cites this paper
• Combined effects of matrix stiffness and obesity-associated signaling directs progressive phenotype in PANC-1 pancreatic cancer cells in vitro

  2024cites this paper
• The New Era of Pancreatic Cancer Treatment: Application of Nanotechnology Breaking Through Bottlenecks.

  2024cites this paper
• Dissection of pro-tumoral macrophage subtypes and immunosuppressive cells participating in M2 polarization

  2024cites this paper
• CRISPR-Cas9 genome and long non-coding RNAs as a novel diagnostic index for prostate cancer therapy via liposomal-coated compounds

  2024cites this paper
• Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics Insights.

  2024cites this paper
• Glutamine-derived aspartate is required for eIF5A hypusination-mediated translation of HIF-1α to induce the polarization of tumor-associated macrophages

  2024cites this paper
• Boron Dipyrromethene-Based Nanotheranostic System for Sonophotoassisted Therapy and Simultaneous Monitoring of Tumor Immune Microenvironment Reprogramming.

  2024cites this paper
• Harnessing innate immune pathways for therapeutic advancement in cancer

  2024cites this paper
• VISTA drives macrophages towards a pro-tumoral phenotype that promotes cancer cell phagocytosis yet down-regulates T cell responses

  2024cites this paper
• Macrophages in tumor cell migration and metastasis

  2024cites this paper
• Cancer spreading patterns based on epithelial-mesenchymal plasticity

  2024cites this paper
• Focus on Pancreatic Cancer Microenvironment

  2024cites this paper
• REDOX SIGNALLING IN THE PANCREAS IN HEALTH AND DISEASE.

  2024cites this paper
• A comprehensive review of 3D cancer models for drug screening and translational research

  2023cites this paper
• Characteristics of ABCC4 and ABCG2 High Expression Subpopulations in CRC—A New Opportunity to Predict Therapy Response

  2023cites this paper
• Enhancing the Treating Efficacy of Immunotherapy through the Restructure of Tumor Microenvironment

  2023cites this paper
• An Update on Gemcitabine-Based Chemosensitization Strategies in Pancreatic Ductal Adenocarcinoma.

  2023cites this paper
• Modulation of tumor-associated macrophage activity with radiation therapy: a systematic review

  2023cites this paper
• Cytokines as drivers: Unraveling the mechanisms of epithelial-mesenchymal transition in COVID-19 lung fibrosis.

  2023cites this paper
• Mannose-functionalization of reconstituted high-density lipoprotein nanoparticles improves payload delivery and enhances M2-to-M1 phenotype reprogramming of RAW 264.7 macrophages polarized by B16-F10 melanoma cells

  2023cites this paper
• Dietary fat and lipid metabolism in the tumor microenvironment.

  2023cites this paper
• Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach

  2023cites this paper
• Vulvo-vaginal epithelial tumors in mares: A preliminary investigation on epithelial-mesenchymal transition and tumor-immune microenvironment

  2023cites this paper
• Polarization of Cancer-Associated Macrophages Maneuver Neoplastic Attributes of Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines

  2023cites this paper
• Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancer

  2023cites this paper
• Role of macrophages in cancer progression and targeted immunotherapies.

  2023cites this paper
• Expression of PD-L1 and VISTA in intraductal papillary mucinous neoplasm with associated invasive carcinoma of the pancreas.

  2023cites this paper
• Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance

  2023cites this paper
• The Cell Biology of Metastatic Invasion in Pancreatic Cancer: Updates and Mechanistic Insights

  2023cites this paper
• Interaction of tumor-associated microglia/macrophages and cancer stem cells in glioma.

  2023cites this paper
• Tumor heterogeneity: An oncogenic driver of PDAC progression and therapy resistance under stress conditions.

  2023cites this paper
• CD4 T cells and neutrophils contribute to epithelial-mesenchymal transition in breast cancer

  2023influential citation
• Bacteria and macrophages in the tumor microenvironment

  2023cites this paper
• Roles of IL-7R Induced by Interactions between Cancer Cells and Macrophages in the Progression of Esophageal Squamous Cell Carcinoma

  2023cites this paper
• Tumor−associated macrophage polarization in the inflammatory tumor microenvironment

  2023cites this paper
• SelectBCM tool: a batch evaluation framework to select the most appropriate batch-correction methods for bulk transcriptome analysis

  2023cites this paper
• The dynamic tumor–stromal crosstalk: implications of ‘stromal-hot’ tumors in the process of epithelial–mesenchymal transition in breast cancer

  2023cites this paper
• Role of tumor-associated macrophages in common digestive system malignant tumors

  2023cites this paper
• Bittersweet Sugars: How Unusual Glycan Structures May Connect Epithelial-to-Mesenchymal Transition and Multidrug Resistance in Cancer

  2023cites this paper
• The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes

  2022cites this paper
• The Effect of the Gut Microbiota on Systemic and Anti-Tumor Immunity and Response to Systemic Therapy against Cancer

  2022cites this paper
• An immune-related gene prognostic risk index for pancreatic adenocarcinoma

  2022cites this paper
• Exosomal CXCL14 Contributes to M2 Macrophage Polarization through NF-κB Signaling in Prostate Cancer

  2022cites this paper
• Targeting tumor-associated macrophages for cancer immunotherapy.

  2022cites this paper
• Extracellular vesicle-mediated crosstalk between pancreatic cancer and stromal cells in the tumor microenvironment

  2022cites this paper
• M1 macrophages induce pro-tumor inflammation in melanoma cells via TNFR-NF-κB signaling.

  2022cites this paper
• Cannabinoid Receptor-1 suppresses M2 macrophage polarization in colorectal cancer by downregulating EGFR

  2022cites this paper
• Progress of tumor-associated macrophages in the epithelial-mesenchymal transition of tumor

  2022cites this paper
• Homophilic ATP1A1 binding induces activin A secretion to promote EMT of tumor cells and myofibroblast activation

  2022cites this paper
• Molecular imaging of tumor-associated macrophages in cancer immunotherapy

  2022cites this paper
• Therapeutic Approaches Targeting Proteins in Tumor-Associated Macrophages and Their Applications in Cancers

  2022cites this paper
• Inflammation Regulation via an Agonist and Antagonists of α7 Nicotinic Acetylcholine Receptors in RAW264.7 Macrophages

  2022cites this paper
• βig-h3-structured collagen alters macrophage phenotype and function in pancreatic cancer

  2022cites this paper
• Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner

  2022cites this paper
• Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.

  2022cites this paper
• Cytokines Chattering in Pancreatic Ductal Adenocarcinoma Tumor Microenvironment.

  2022cites this paper
• miR-382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor-associated macrophages by targeting PGC-1α

  2022cites this paper
• LncRNA TP73‐AS1 promotes nasopharyngeal carcinoma progression through targeting miR-342-3p and M2 polarization via exosomes

  2022cites this paper
• HDAC4 Mediates Smoking-Induced Pancreatic Cancer Metastasis

  2022cites this paper